These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 27416146)

  • 1. In Vitro Activity of Tigemonam Against Urinary Tract Pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1(sup2):28-31. PubMed ID: 27416146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activity of Tigemonam Against Multiresistant Nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1(sup2):32-35. PubMed ID: 27416147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro activity of cefodizime: a review.
    Soussy CJ; Chanal M; Kitzis MD
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal Activity of Tigemonam, Alone and in Combination with Gentamicin.
    Shah PM; Gànger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1(sup2):45-46. PubMed ID: 27416150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
    Shah PM; Gänger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The In Vitro Activity of Tigemonam: a Comparison with Other Antimicrobial Agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1(sup2):5-12. PubMed ID: 27416143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial Activity In Vitro of Tigemonam, a New Oral Monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1(sup2):41-44. PubMed ID: 27416149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
    Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
    Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.